Steven Harold Goldman is Director at STELLAR PHARMACEUTICALS INC (SLXCF). They have made 7 open-market trades across 2 companies since 2010, most recently 2013-02-27.
CIK 0001489399
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $632K since 2012, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TBUFF | BUY | 2013-02-27 | 2013-03-04 | $0.40 | $500K | N/A | N/A | N/A |
| SLXCF | BUY | 2012-11-19 | 2012-11-21 | $0.35 | $35K | N/A | N/A | N/A |
| SLXCF | BUY | 2012-09-07 | 2012-09-14 | $0.50 | $13K | N/A | N/A | N/A |
| SLXCF | BUY | 2012-09-04 | 2012-09-06 | $0.50 | $52K | N/A | N/A | N/A |
| SLXCF | BUY | 2012-08-31 | 2012-08-31 | $0.48 | $17K | N/A | N/A | N/A |
| SLXCF | BUY | 2012-08-27 | 2012-08-29 | $0.38 | $15K | N/A | N/A | N/A |
| SLXCF | SELL | 2010-08-26 | 2010-08-31 | $0.86 | $228 | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.